ACC Seeks Fraud Charges Against Former IGMH Executives Over PCR Test Reagents Case

The Anti-Corruption Commission (ACC) has recommended the filing of an FIR against three former senior officials of Indira Gandhi Memorial Hospital (IGMH) in connection with alleged fraudulent activities during the COVID-19 pandemic. The individuals implicated include Dr. Ali Abdulla Latheef, former CEO Ibrahim Saleem, and former head of the laboratory Dr. Milza Abdul Muhsin. The accusations stem from allegations that they provided "reagents" used in the hospital's PCR testing to a company with vested interests, violating procurement protocols.

The Prosecutor General's Office has already filed a charge sheet against the three former officials. Dr. Milza Abdul Muhsin, who held multiple key roles including chairman of the procurement committee and member of the medical executive committee, is accused alongside the others of abusing their official positions for undue favors and personal gain.

In light of these allegations, the court has requested the formal registration of complaints against all three accused. The ACC has also requested the police to investigate potential money laundering activities related to Dr. Ali Abdulla Latheef's involvement with RMLS Lab Services. This investigation has raised suspicions of financial misconduct, prompting further scrutiny.

Additionally, the ACC has asked the Maldives Inland Revenue Authority (MIRA) to investigate claims of tax fraud by Dr. Ali Abdulla Latheef, based on documents he submitted that allegedly indicate tax-related discrepancies. Both Dr. Milza and Dr. Ali Abdulla Latheef have been instructed to address the issues identified in the case before the Commission and the Maldives Medical Council.

These developments mark a significant step in the ongoing investigation into the alleged misuse of public resources during the pandemic, highlighting the ACC's commitment to ensuring accountability and transparency in the healthcare sector.